US2023389830A1PendingUtilityA1
Continuous analyte measurement systems and systems and methods for implanting them
Est. expiryJul 23, 2029(~3 yrs left)· nominal 20-yr term from priority
A61B 5/14532A61B 5/14865A61B 5/6833A61B 2560/0443A61B 2562/227A61B 5/002A61B 5/7221A61B 5/1495
84
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Low profile continuous analyte measurement systems and systems and methods for implantation within the skin of a patient are provided.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A glucose monitoring system comprising:
a data processing unit configured to be mounted on a skin surface including:
one or more processors,
one or more memories coupled with the one or more processors,
a battery coupled to the one or more processors,
an RF transmitter/receiver coupled to the one or more processors, and
a fixation element comprising an adhesive configured to secure the data processing unit to the skin surface;
a glucose sensor configured to generate electrical signals indicative of levels of glucose in an interstitial fluid, the glucose sensor including:
a proximal portion electrically coupled to the one or more processors of the data processing unit, and
a distal portion configured to be inserted through the skin surface and in contact with the interstitial fluid, the distal portion including:
a plurality of electrodes including a working electrode and a second electrode, wherein the second electrode comprises a reference electrode, and
an enzyme comprising glucose oxidase disposed proximate the working electrode;
wherein the glucose sensor comprises a predictable in vivo sensitivity drift and the one or more memories have a drift profile stored thereon; wherein the one or more memories store instructions which, when executed by the one or more processors determine a glucose level based on the electrical signals generated by the glucose sensor and the drift profile; and wherein the glucose monitoring system does not require user-initiated calibration during a life of the glucose sensor extending between 3 and 14 days.
2 . The glucose monitoring system of claim 1 , wherein the second electrode further comprises a counter electrode.
3 . The glucose monitoring system of claim 1 , wherein the distal portion of the glucose sensor further comprises a mass transport limiting layer configured to reduce a rate of mass transport of glucose into a region proximate the working electrode.
4 . The glucose monitoring system of claim 3 , wherein the mass transport limiting layer comprises a zwitterionic moiety.
5 . The glucose monitoring system of claim 3 , wherein the mass transport limiting layer comprises at least one of a poly(ethylene glycol) modifier, hydroxyl modifier, and polyhydroxyl modifier.
6 . The glucose monitoring system of claim 1 , where the distal portion of the glucose sensor further comprises an interferent eliminating layer disposed between the working electrode and the glucose oxidase.
7 . The glucose monitoring system of claim 1 , wherein the distal portion of the glucose sensor comprises a first width of 0.15 mm or less.
8 . The glucose monitoring system of claim 7 , wherein the proximal portion of the glucose sensor comprises a second width, wherein the first width and the second width are substantially the same.
9 . The glucose monitoring system of claim 1 , wherein the data processing unit further comprises a temperature detection section operatively coupled to the one or more processors.
10 . The glucose monitoring system of claim 9 , wherein the instructions, when executed by the one or more processors, determine the glucose level based further on a temperature measurement determined by the temperature detection section.
11 . The glucose monitoring system of claim 1 , where in the data processing unit further comprises a clock configured to supply real time information to the one or more processors.
12 . The glucose monitoring system of claim 1 , wherein the glucose sensor detects hydrogen peroxide to generate the electrical signals indicative of levels of glucose.
13 . The glucose monitoring system of claim 1 , further comprising a receiver unit including:
one or more receiver processors; one or more receiver memories coupled with the one or more receiver processors; a receiver RF receiver/transmitter coupled to the one or more receiver processors and configured to communicate with the RF receiver/transmitter of the data processing unit via a communication link; and a battery coupled to the one or more receiver processors.
14 . The glucose monitoring system of claim 13 , wherein the communication link uses a Bluetooth enabled communication protocol.
15 . The glucose monitoring system of claim 13 , wherein the system is configured to provide an alarm when a glucose condition is detected based at least in part on the determined glucose level.
16 . The glucose monitoring system of claim 15 , wherein the glucose condition comprises hypoglycemia.
17 . The glucose monitoring system of claim 15 , wherein the glucose condition comprises hyperglycemia.
18 . The glucose monitoring system of claim 15 , wherein the glucose condition comprises impending hypoglycemia.
19 . The glucose monitoring system of claim 15 , wherein the glucose condition comprises impending hyperglycemia.
20 . The glucose monitoring system of claim 15 , wherein the alarm comprises an auditory and visual alarm.
21 . The glucose monitoring system of claim 14 , wherein the alarm comprises a vibratory and visual alarm.
22 . The glucose monitoring system of claim 1 , further comprising an insertion device having an insertion needle having an opening configured to receive the distal portion of the glucose sensor.
23 . The glucose monitoring system of claim 22 , wherein the opening comprises a longitudinal opening having a u-shaped cross-section.
24 . The glucose monitoring system of claim 22 , wherein the opening comprises a longitudinal opening having a v-shaped cross section.
25 . The glucose monitoring system of claim 22 , wherein the opening comprises a longitudinal opening having a c-shaped cross section.
26 . The glucose monitoring system of claim 22 , wherein the insertion device further comprises a body having a distal base portion, the distal base portion including a bottom surface configured for placement on the skin surface.
27 . The glucose monitoring system of claim 26 , where in the insertion device further comprises a plunger positioned within the body and movable perpendicular to the skin surface, the plunger coupled to the insertion needle.
28 . The glucose monitoring system of claim 27 , wherein the insertion device further comprises a spring providing a bias on the plunger to retract the insertion needle after the sensor is inserted through the skin surface.
29 . The glucose monitoring system of claim 28 , wherein the insertion device comprises a plastic.
30 . The glucose monitoring system of claim 29 , wherein the insertion device is disposable.Join the waitlist — get patent alerts
Track US2023389830A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.